Phase 2 Start~month

Phase 2 Start: A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Ame

Indication
Duchenne Muscular Dystrophy (DMD)

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Ame — TRDA Phase 2 Start | BioSniper